Intravenous Iron Therapy to Treat Anemia in Oncology: A Mapping Review of Randomized Controlled Trials
Anemia is a common problem when patients present with cancer, and it can worsen during treatment. Anemia can directly impact the cognitive and physical quality of life and may impair fitness for oncological therapy. The most common cause of anemia is iron deficiency. Newer intravenous (IV) iron form...
Main Authors: | Jayne Lim, Michael Auerbach, Beth MacLean, Annas Al-Sharea, Toby Richards |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/30/9/569 |
Similar Items
-
Treatment with intravenous iron in postpartum anaemia
by: Jayne Lim, et al.
Published: (2024-03-01) -
The prevalence of iron deficiency and anemia and their impact on survival in patients at a cardio-oncology clinic
by: E. Čiburienė, et al.
Published: (2020-12-01) -
Role of intravenous iron in the treatment of anemia in patients with gastrointestinal tract tumors undergoing chemotherapy: a single-center, observational study
by: Lima J, et al.
Published: (2018-08-01) -
Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia
by: João Ricardo Friedrisch, et al.
Published: (2015-12-01) -
The efficiency and safety of Shengxuening tablet on treating and preventing iron deficiency anemia: A systematic review and meta-analysis
by: Yanyu Zhang, et al.
Published: (2022-11-01)